Lung cancer cell invasion and expression of intercellular adhesion molecule-1 (ICAM-1) are attenuated by secretory phospholipase A 2 inhibition

Journal of Thoracic and Cardiovascular Surgery

Volumn 143, Issue 2, 2012, Pages 405-411

  Yu, Jessica A ^a   Sadaria, Miral R ^a   Meng, Xianzhong ^a   Mitra, Sanchayita ^a   Ao, Lihua ^a   Fullerton, David A ^a   Weyant, Michael J ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; MESSENGER RNA; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR;

ANALYSIS OF VARIANCE; ARTICLE; CANCER CELL; CANCER INVASION; CELL INVASION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; LUNG ADENOCARCINOMA; LUNG CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; STUDENT T TEST;

ADENOCARCINOMA; ANALYSIS OF VARIANCE; ANTIBODIES, NEUTRALIZING; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LUNG NEOPLASMS; MICROSCOPY, FLUORESCENCE; NEOPLASM INVASIVENESS; PHOSPHOLIPASES A2, SECRETORY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84862975389     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2011.10.026     Document Type: Article

References (25)

1. Surveillance Epidemiology and End Results, Cancer Statistics Review 2010 National Cancer Institute Bethesda
2. N. Makrilia, A. Kollias, L. Manolopoulos, and K. Syrigos Cell adhesion molecules: role and clinical significance in cancer Cancer Invest 27 2009 1023 1037
3. C.L. Roland, A.H. Harken, M.G. Sarr, and C.C. Barnett ICAM-1 expression determines malignant potential of cancer Surgery 141 2007 705 707 (Pubitemid 46863445)
4. A. Gogali, K. Charalabopoulos, I. Zampira, A.K. Konstantinidis, F. Tachmazoglou, and G. Daskalopoulos Soluble adhesion molecules E-cadherin, intercellular adhesion molecule-1, and E-selectin as lung cancer biomarkers Chest 138 2010 1173 1179
5. A. Grothey, P. Heistermann, S. Philippou, and R. Voigtmann Serum levels of soluble intercellular adhesion molecule-1 (ICAM-1, CD54) in patients with non-small-cell lung cancer: correlation with histological expression of ICAM-1 and tumour stage Br J Cancer 77 1998 801 807 (Pubitemid 28077470)
6. M. Kamiyoshihara, O. Kawashima, Y. Otani, and Y. Morishita Clinical significance of the preoperative serum-soluble intercellular adhesion molecule-1 in non-small cell lung cancer J Cardiovasc Surg (Torino) 43 2002 729 734 (Pubitemid 35414711)
7. Y.C. Lin, C.T. Shun, M.S. Wu, and C.C. Chen A novel anticancer effect of thalidomide: inhibition of intercellular adhesion molecule-1-mediated cell invasion and metastasis through suppression of nuclear factor-kB Clin Cancer Res 12 2006 7165 7173
8. B. Passlick, K. Pantel, B. Kuboschok, M. Angstwurm, A. Neher, and O. Thetter Expression of MHC molecules and ICAM-1 on non-small cell lung carcinomas: association with early lymphatic spread of tumour cells Eur J Cancer 32A 1996 141 145
9. L.M. Chen, C.H. Kuo, T.Y. Lai, Y.M. Lin, C.C. Su, and H.H. Hsu RANKL increases migration of human lung cancer cells through intercellular adhesion molecule-1 up-regulation J Cell Biochem 112 2011 933 941
10. L. Thommesen, W. Sjursen, K. Gasvik, W. Hanssen, O.L. Brekke, and L. Skattebol Selective inhibitors of cytosolic or secretory phospholipase A2 block TNF-induced activation of transcription factor nuclear factor-kappaB and expression of ICAM-1 J Immunol 161 1998 3421 3430
11. L. Fuentes, M. Hernández, F.J. Fernández-Avilés, M.S. Crespo, and M.L. Nieto Cooperation between secretory phospholipase A2 and TNF-receptor superfamily signaling Circ Res 91 2002 681 688
12. M.C.M. Weiser-Evans, X.Q. Wang, J. Amin, V.V. Putten, R. Choudhary, and R.A. Winn Depletion of cytosolic phospholipase A2 in bone marrow-derived macrophages protects against lung cancer progression and metastasis Cancer Res 69 2009 1733 1738
13. J.N. Ho, S.B. Lee, S.S. Lee, S.H. Yoon, G.Y. Kang, and S.G. Hwang Phospholipase A2 activity of peroxiredoxin 6 promotes invasion and metastasis of lung cancer cells Mol Cancer Ther 9 2010 825 832
14. 2 is required to produce histologic changes associated with gastroduodenal reflux in a murine model J Thorac Cardiovasc Surg 135 2008 1220 1227 (Pubitemid 351787654)
15. 2 J Thorac Cardiovasc Surg 139 2010 591 599
16. 2 inhibition attenuates intercellular adhesion molecule-1 expression in human esophageal adenocarcinoma cells Ann Thorac Surg 91 2011 1539 1545
17. J.A. Yu, M.R. Sadaria, X. Meng, D.A. Fullerton, and M.J. Weyant Secretory phospholipase A2 inhibition promotes apoptosis in lung cancer cells and modulates ERK 1/2 activation J Thorac Oncol 6 2011 S660
18. K. Yokote, N. Morisaki, M. Zenibayashi, S. Ueda, T. Kanzaki, and Y. Saito The phospholipase-A2 reaction leads to increased monocyte adhesion of endothelial cells via the expression of adhesion molecules Eur J Biochem 217 1993 723 729 (Pubitemid 23311986)
19. W. Van Veelan, S.E. Korsse, L. van de Laar, and M.P. Peppelenbosch The long and winding road to rational treatment of cancer associated with LKB1/AMPK/TSC/mTORC1 signaling Oncogene 30 2011 2289 2303
20. A.D. Ricart Immunoconjugates against solid tumors: mind the gap Clin Pharmacol Ther 89 2011 512 523
21. T.L. McLemore, W.C. Hubbard, C.L. Litterst, M.C. Liu, S. Miller, and N.A. McMahon Profiles of prostaglandin biosynthesis in normal lung and tumor tissue from lung cancer patients Cancer Res 48 1988 3140 3147
22. K.L. Reckamp, B.K. Gardner, R.A. Figlin, D. Elashoff, K. Krysan, and M. Dohadwala Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherin J Thorac Oncol 3 2008 116 124
23. Y. Wu, and B.P. Zhou TNF-α/NF-κB/Snail pathway in cancer cell migration and invasion Br J Cancer 102 2010 639 644
24. B.G. Zeiher, J. Steingrub, P.F. Laterre, A. Dmitrienko, Y. Fukijishi, and E. Abraham EZZI Study Group. LY31590NA/S-5920, a selective inhibitor of group IIA secretory phospholipase A2, fails to improve clinical outcome for patients with severe sepsis Crit Care Med 33 2005 1741 1748 (Pubitemid 41153699)
25. J.D. Bradley, A.A. Dmitrienko, A.J. Kivitz, O.S. Gluck, A.L. Weaver, and C. Wisenhutter A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis J Rheumatol 32 2005 417 423 (Pubitemid 40381410)